Improving cervical cancer screening and treatment for HIV positive women in Kenya
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
This study is working to help women with HIV in Kenya get better access to cervical cancer screenings and treatments, so they can catch any issues early and improve their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11177272 on NIH RePORTER |
What this research studies
This research focuses on enhancing the adoption of cervical cancer screening and ensuring effective treatment linkage for HIV positive women in Kenya. It aims to address the significant gaps in healthcare access and cancer treatment that lead to late-stage cancer diagnoses. By collaborating with various institutions and engaging community stakeholders, the project seeks to implement evidence-based practices and improve health outcomes for women. The approach includes training healthcare providers and utilizing implementation science to create sustainable healthcare solutions.
Who could benefit from this research
Good fit: Ideal candidates for this research are HIV positive women living in Kenya who are at risk for cervical cancer.
Not a fit: Patients who are not HIV positive or those who do not reside in Kenya may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of late-stage cervical cancer among HIV positive women in Kenya, leading to better health outcomes and quality of life.
How similar studies have performed: Previous research has shown success in improving cancer screening and treatment linkage in similar populations, indicating that this approach has the potential for positive outcomes.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Kosgei, Rose Jepchumba — Emory University
- Study coordinator: Kosgei, Rose Jepchumba
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.